Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-10

Clinical Trial Update: Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial [Phase 4]

View source ↗

Summary

Phase 4 head-to-head trial comparing olopatadine 0.6% nasal spray with fluticasone propionate 50 mcg nasal spray in seasonal allergic rhinitis; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flonase nasal spray (fluticasone propionate)
  • Patanase nasal spray (olopatadine)

Snippet

Sponsor: Alcon Research | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2010-03-10